Survival in older women with early stage breast cancer receiving low-dose bisphosphonates or denosumab.

Maria E Suarez-AlmazorRaul HerreraXiudong LeiMariana Chavez Mac Gregor Hui Zhao Sharon H Giordano

Published in: Cancer (2020)

Bisphosphonates at the doses recommended for osteoporosis are associated with improved survival in older postmenopausal women with early breast cancer.

Keyphrases

bone mineral density
early stage
low dose
early breast cancer
postmenopausal women
free survival
high dose
physical activity
middle aged
squamous cell carcinoma
community dwelling
neoadjuvant chemotherapy